Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of 1,76,900 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 '.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jagsonpal Pharmaceuticals has allotted 176,900 equity shares of Rs. 2 each to eligible employees under the JPL ESOP 2022 scheme. The shares were issued at exercise prices ranging from Rs. 94 to Rs. 115.60 per share, with premiums of Rs. 92 to Rs. 113.60 per share over the face value. Following this allotment, the company's paid-up share capital increased from Rs. 13,39,24,500 to Rs. 13,42,78,300, and the total number of equity shares rose from 6,69,62,250 to 6,71,39,150. The new shares will rank pari-passu with existing equity shares and carry no lock-in restrictions.
This is a routine ESOP-driven dilution with minimal share count increase of about 0.26%. The impact on existing shareholders is negligible, and the new shares are immediately tradable on par with existing shares.